Drug intelligence / Profile preview

Compound Eleutherococcus senticosus Granule

Development stage
Unknown
Lead developer
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Compound Eleutherococcus senticosus Granule is a traditional herbal preparation primarily containing Eleutherococcus senticosus, also known as Siberian ginseng or eleuthero. This woody shrub, native to Northeast Asia, has been utilized in Traditional Chinese, Korean, and Japanese medicine for over two millennia. It is recognized for its adaptogenic properties, which help enhance the body's resistance to stress, improve mental and physical endurance, and stimulate the immune system. The pharmacological effects are attributed to various bioactive compounds, including eleutherosides, lignans, saponins, flavonoids, and polysaccharides. The compound granule is currently undergoing clinical investigation for the treatment of insomnia, particularly in cases associated with 'heart and spleen deficiency syndrome' in Traditional Chinese Medicine. Its mechanism of action involves modulating neurotransmitter levels, such as increasing inhibitory neurotransmitters like serotonin (5-HT) and gamma-aminobutyric acid (GABA), while reducing excitatory ones like dopamine (DA) and norepinephrine (NE), thereby contributing to improved sleep. Additionally, it exhibits anti-inflammatory, immunomodulatory, and neuroprotective activities.

Other names
Ciwujia Tablet
02

Targets

MAPK3 (Mitogen-activated protein kinase 1)BDNF (Brain-derived neurotrophic factor)NF-κBAKT (RAC-alpha serine/threonine-protein kinase)

Beyond the preview

Go deeper on Compound Eleutherococcus senticosus Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Eleutherococcus senticosus Granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call